As our Clinician In-Residence, you will be the medical voice across product, clinical operations, regulatory strategy, patient experience, and research as we bring breath-based cancer detection to the world. About the Role This is a cross-functional medical role, involving work across product, clinical operations, medical affairs, regulatory, patient experience, and research. Dognosis runs a multi-site prospective clinical study under ICH-GCP and Indian GCP compliance, and is preparing for commercial rollout. You will be embedded across both: shaping protocols and ensuring scientific rigor today, and helping build the medical foundation for a consumer screening product tomorrow. What You'll Do • Shape study protocols and clinical workflows alongside the Clinical & Founding Team. • Shape the user experience and customer journey for our breath-based product(s) for MCED (multi-cancer early detection) and recurrence monitoring. • Build and iterate on the counselling workflow for BreathEasy users on their screening results and serve as the medical point of contact for patient-facing interactions. • Contribute to research publications and represent Dognosis at scientific conferences. What You Need • MBBS with registration to practice in India, and ideally in Karnataka. • Strong communication skills. You can explain complex medical concepts in simple terms to customers and the general public, while retaining strong clinical confidence with clinicians. • Genuine interest in product development. You want to shape how diagnostics reach people. • Comfort in unstructured environments where you define your own priorities and work across functions. • Interest in research and figuring out novel care pathways. Nice to have • Experience in clinical research, whether during training, residency, or independently. • Experience in public-facing community (blog, social media, educational content). • Experience in product development. What You'll Get • Potential co-authorship on research in top-tier journals. Dognosis has been published in the Journal of Clinical Oncology and presents frequently at ASCO, AACR, Cancer Research UK. • Network and interactions with leading hospitals in India and the USA (Narayana Health, KMCRI, Tata Memorial, Harvard's Dana-Farber Cancer Institute) and globally renowned researchers. • Competitive salary and matching perks at a company backed by Accel, Berkeley's The House Fund, and other leading global investors. • Working with a high-touch interdisciplinary team spanning engineers, scientists, and working detection dogs. The office is never boring. • Ownership over a novel product with potential for a paradigm-shift in oncology and how we detect and treat cancer.